Overview

Introduction
Bionest Partners is a healthcare and health tech consultancy founded in 2006. Acquired by Accenture in 2023, the firm offers specialized services for businesses focused on rare diseases, gene therapy, and precision medicine. These include capital raising, partnership, M&A, and valuation advisory.
Company Stats
Employer Type
Featured Rankings
Major Office Locations
Senior Manager - Paris
Principal - Paris
About the Company
Bionest Partners is a healthcare and healthtech consultancy that helps clients navigate the healthcare and health tech landscape to develop successful commercial, medical, and access strategies. Supporting clients whose products include advanced therapeutics, precision medicine, and treatments for rare diseases, the firm offers a wide range of services, from go-to-market strategies to financial advising to policy and advocacy.
One example of the firm’s work is its efforts to set up an E.U. advocacy strategy for gene therapy. Working with a U.S.-based biotechnology company, it developed a cross-functional plan to shape the EU payer and political landscape to help bring the technology to market. In another example, the firm helped a different U.S. biotech company enter the European market, building a revenue forecast and recommending...